ALI Tests for Trichomonas, Chlamydia, and Gonorrhea

Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) are two of the most common agents of sexually transmitted diseases in the United States and in the world. In the U.S., CT infection and GC infection rank as the most common and second most common notifiable diseases, respectively. According to the CDC, Trichomonas vaginalis (TV) is the most common curable sexually transmitted disease.  In the United States, an estimated 3.7 million people have trichomoniasis, but only about 30% develop symptoms.

Several methods have been used for detection of CT, GC, and TV in clinical samples. Nucleic acid amplification testing (NAAT) is the most sensitive type of assay for detection of these organisms. In addition, the use of NAAT allows for less invasive specimen collection for CT, GC, and TV. The Hologic Aptima system is a very sensitive and specific transcription-mediated amplification (TMA) method that targets and amplifies ribosomal RNA (rRNA) from all three organisms with just one sample!

ALI offers the following orderable tests for STIs using Nucleic Acid Amplification Test (NAAT) technology with the Hologic Aptima system:
  • STD Tri Panel - Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis (C STD TRI PAN)
  • STD Panel - Chlamydia trachomatis and Neisseria gonorrhoeae (C STD PAN)
  • Chlamydia trachomatis (C CT)
  • Neisseria gonorrhoeae (C GC)
  • Trichomonas vaginalis (C TVAG)
Click Here to view the ‘CDC Treatment Guidelines’ for chlamydia, gonorrhea, and trichomoniasis